FDA Approves Libido Pill for Women

LET’S GET IT ON

Updated Apr. 14, 2017 10:10AM EDT / Published Aug. 18, 2015 7:38PM EDT

The Food and Drug Administration on Tuesday approved a libido prescription drug for women, after a long lobbying campaign accused the agency of gender bias. Addyi is now the first drug to treat absent libido for either sex. There are concerns that the drug is only minimally effective and could cause low blood pressure, fainting, and dizziness. It is unclear how big the market is for the drug, but one study said 10 percent of women suffer from hypoactive sexual desire disorder, which Addyi is meant to treat.

Read it at The New York Times

Melania Privately Trashes Trump Trial as a ‘Disgrace’: NYT

She’d reportedly told those close to her it’s “his problem” but that doesn’t mean she thinks it’s fair.

O.J.’s Executor Backpedals on Goldman Family Payout

When he died last week, Simpson still owed Ron Goldman’s relatives more than $100 million as part of a wrongful death judgment.

Juror Dishes After Getting Dismissed From Trump Jury Pool

The seemingly “larger-than-life” ex-president is no different than anyone else, Kara McGee told CNN.

Travis Kelce Will Host A Star-Studded Game Show Reboot

“I grew up loving game shows, and I’m excited to be following in the footsteps of so many TV icons by hosting my very first one,” he said.

Bollywood Star’s Home Shot Up Over 1998 Killing of Antelopes

Two suspects in the attack reportedly belong to a gang from a religious sect for which the animals hold a special significance.

DOJ Gears Up to Bring Ticketmaster Antitrust Lawsuit: Report

The case could be filed as early as May.

Alarms Went Off on Ship Hours Before Bridge Crash: Report

The Dali had not even left port when the alarms were triggered.

Trump Team Scheming to Devalue Dollar if He Wins: Report

It’s an aggressive move designed to reduce the trade deficit—but risks losing the dollar’s coveted status as world reserve currency.

FDA Approves Libido Pill for Women